Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease has emerged in recent decades as a major health problem and the role of lifestyles in the modulation of risk has been increasingly recognized. Recent epidemiological studies suggest a protective effect for caffeine intake in dementia. We aimed to quantify the association between caffeine dietary intake and cognitive decline, in a cohort of adults living in Porto. A cohort of 648 subjects aged > or =65 years was recruited between 1999-2003. Follow-up evaluation (2005-2008) was carried out on 58.2% of the eligible participants and 10.9% were deceased. Caffeine exposure in the year preceding baseline evaluation was assessed with a validated food frequency questionnaire. Cognitive evaluation consisted of baseline and follow-up Mini-Mental State Examination (MMSE). Cognitive decline was defined by a decrease > or =2 points in the MMSE score between evaluations. Relative risk (RR) and 95% confidence interval (95%CI) estimates adjusted for age, education, smoking, alcohol drinking, body mass index, hypertension, and diabetes were computed using Poisson regression. Caffeine intake (> 62 mg/day [3rd third] vs. < 22 mg/day [1st third]) was associated with a lower risk of cognitive decline in women (RR=0.49, 95%CI 0.24-0.97), but not significantly in men (RR=0.65, 95%CI 0.27-1.54). Our study confirms the negative association between caffeine and cognitive decline in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while 5 recent studies detected this association only among women or for specific exposures [165,169,171-173]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [172]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 2×
“The results were similar when considering the traditional MMSE cut-off of 24 points [15] to define cognitive impairment, instead of the normative”
MethodResultChobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152 · cited 1×
“clinically significant cognitive decline [18].”
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
BackgroundChobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793 · cited 1×
“Arterial hypertension was defined as systolic blood pressure 140 mmHg and/or diastolic blood pressure 90 mmHg and/or current antihypertensive drug therapy [24].”
BackgroundHuman blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C., Flack, J., Frohlich, E. D., Hill, M., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,591 · cited 2×
“Blood pressure was measured on a single occasion by non-physician trained interviewers, using a mercury sphygmomanometer, taking phase I and V Korotkoff sounds as systolic and diastolic blood pressure, respectively, and following the recommendations of the American Heart Association [23].”
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 3×
“The results obtained are in agreement with several previously reports which suggested that caffeine reduces the risk of dementia or cognitive decline [7,8,11, 12,40].”
Diabetes Mellitus: Report of a WHO Study Group.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-597_2 · Cited by 1,022
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
BackgroundMeta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · cited 1×
“Ascherio and collaborators reported a strong inverse association in men and a U-shaped relationship in women, with the lowest risk of Parkinson’s disease occurring at moderate intakes [53].”
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
Alcohol, dementia and cognitive decline in the elderly: a systematic review
Peters, R., Peters, J., Warner, J., Beckett, N., & Bulpitt, C. (2008) · Age and Ageing · doi:10.1093/ageing/afn095 · Cited by 453 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428 · cited 1×
“The results obtained are in agreement with several previously reports which suggested that caffeine reduces the risk of dementia or cognitive decline [7,8,11, 12,40].”
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 370
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357 · cited 3×
“A small case-control study suggested that caffeine exposure was significantly inversely associated with AD [7].”
BackgroundResultCanas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 357
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Self-citationEducation and dementia: a meta-analytic study
Caamaño-Isorna, F., Corral, M., Montes-Martínez, A., & Takkouche, B. (2006) · Neuroepidemiology · doi:10.1159/000093378 · Cited by 288 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
Willett, W. (2012) · Nutritional Epidemiology · doi:10.1093/acprof:oso/9780199754038.003.0005 · Cited by 281
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Patterson, C., Feightner, J. W., Garcia, A., Hsiung, G.-Y. R., MacKnight, C., & Sadovnick, A. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070796 · Cited by 268 · cited 1×
“The role of lifestyles in the prevention of AD has been emphasised [2], as had been the case for Parkinson’s disease, another neurodegenerative condition sharing similarities with AD [3].”
BackgroundEffect of Education on the Mini‐Mental State Examination as a Screening Test for Dementia
Uhlmann, R. F., & Larson, E. B. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb04454.x · Cited by 250 · cited 1×
“proposed in other studies [19,20].”
Tea consumption and cognitive impairment and decline in older Chinese adults
Ng, T.-P., Feng, L., Niti, M., Kua, E.-H., & Yap, K.-B. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.224 · Cited by 236 · cited 1×
“Previous studies on this topic defined cognitive decline as a variation of 2 or more points in the MMSE score over a 3-year period [12], or a variation in at least one point in MMSE over a 1-year period [43].”
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234 · cited 1×
“These authors described an interaction between the use of postmenopausal hormones and caffeine intake in the risk of Parkinson’s disease, with an increased risk among women on hormonal replacement therapy with a high caffeine intake [54,55], although the reasons for this effect modification are not yet clear.”
BackgroundAscherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh312 · Cited by 232 · cited 1×
“These authors described an interaction between the use of postmenopausal hormones and caffeine intake in the risk of Parkinson’s disease, with an increased risk among women on hormonal replacement therapy with a high caffeine intake [54,55], although the reasons for this effect modification are not yet clear.”
van Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228 · cited 2×
“The results obtained are in agreement with several previously reports which suggested that caffeine reduces the risk of dementia or cognitive decline [7,8,11, 12,40].”
Sensitivity and Specificity of the Mini-Mental State Examination in a Spanish-Speaking Population
Ostrosky-Solís, F., López-Arango, G., & Ardila, A. (2000) · Applied Neuropsychology · doi:10.1207/s15324826an0701_4 · Cited by 174 · cited 1×
“proposed in other studies [19,20].”
Coffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow, M. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf119 · Cited by 173 · cited 1×
“Other epidemiological studies used a different approach, assessing whether caffeine consumption could influence cognitive decline, with conflicting results [9–11].”
ResultRamos, E., Lopes, C., & Barros, H. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.09.013 · Cited by 160 · cited 2×
“When comparing men and women who did and did not accept to participate, there were no differences regarding marital status, education, or occupation [14].”
Self-citationCigarette Smoking and Dementia: Potential Selection Bias in the Elderly
Hernán, M. A., Alonso, A., & Logroscino, G. (2008) · Epidemiology · doi:10.1097/ede.0b013e31816bbe14 · Cited by 159 · cited 3×
“The impact of survival bias tends to increase with the age of the cohort members at baseline [45].”
Course of cognitive decline in Parkinson's disease: A meta-analysis
MUSLIMOVIĆ, D., SCHMAND, B., SPEELMAN, J. D., & DE HAAN, R. J. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707071160 · Cited by 148 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
Hypertension, cognitive decline and dementia
Duron, E., & Hanon, O. (2008) · Archives of Cardiovascular Diseases · doi:10.1016/s1875-2136(08)71801-1 · Cited by 123 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
BackgroundTebano, M. T., Martire, A., Rebola, N., Pepponi, R., Domenici, M. R., Grò, M. C., Schwarzschild, M. A., Chen, J. F., Cunha, R. A., & Popoli, P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03455.x · Cited by 121 · cited 1×
“Experimental studies conducted in animal models have also shown that adenosine A2A and metabotropic glutamate 5 receptors are co-located and that the former play a permissive role in mGlu5R receptor-mediated potentiation of NMDA effects in the hippocampus [6].”
Habitual coffee consumption and blood pressure: An epidemiological perspective
Geleijnse, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3055 · Cited by 117 · cited 1×
“Even though most epidemiological evidence suggests that regular intake of caffeinated coffee does not increase the risk of hypertension [50], general public awareness makes hypertensive patients less likely to drink coffee [51].”
BackgroundThe effects of habitual caffeine use on cognitive change: a longitudinal perspective
VANBOXTEL, M., SCHMITT, J., BOSMA, H., & JOLLES, J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00171-0 · Cited by 110 · cited 1×
“Other epidemiological studies used a different approach, assessing whether caffeine consumption could influence cognitive decline, with conflicting results [9–11].”
ResultCaffeine, cognitive failures and health in a non‐working community sample
Smith, A. P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.991 · Cited by 102 · cited 1×
“In a recently published study, Smith and colleagues concluded that caffeine consumption was found to be associated with a reduced risk of depression [52].”
Smoking, alcohol, and dietary choices: evidence from the Portuguese National Health Survey
Padrão, P., Lunet, N., Santos, A. C., & Barros, H. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-138 · Cited by 91
Self-citationRapid cognitive decline in Alzheimer's disease. Consensus paper
Soto, M. E., Andrieu, S., Arbus, C., Ceccaldi, M., Couratier, P., Dantoine, T., Dartigues, J. F., Gillette-guyonette, S., Nourhashemi, F., Ousset, P. J., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf03028618 · Cited by 82 · cited 1×
“A consensus paper recently published suggested that a decrease of 3 or more points in MMSE for a period of six months could be used to define rapid cognitive decline in patients with mild to moderately severe AD [42], and it is reasonable to assume that it corresponds to a clinically meaningful deterioration also in s…”
Yoshimura, H. (2005) · Current Neuropharmacology · doi:10.2174/157015905774322543 · Cited by 78 · cited 1×
“Caffeine is widely consumed worldwide and acts as a nonspecific antagonist of adenosine receptors [4].”
Coffee drinking in middle age is not associated with cognitive performance in old age
Laitala, V. S., Kaprio, J., Koskenvuo, M., Räihä, I., Rinne, J. O., & Silventoinen, K. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27660 · Cited by 70 · cited 1×
“Nevertheless, the ascertainment of cognitive status was performed only at the follow-up evaluation and by telephone interview [41].”
Consensus Document on European Brain Research
Di Luca, M., Baker, M., Corradetti, R., Kettenmann, H., Mendlewicz, J., Olesen, J., Ragan, I., & Westphal, M. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07596.x · Cited by 63 · cited 1×
“Alzheimer’s disease (AD) and other aging-related neurodegenerative disorders have emerged in the last decades as a major health problem in our society [1].”
Smoking patterns in a community sample of Portuguese adults, 1999–2000
Santos, A. C., & Barros, H. (2003) · Preventive Medicine · doi:10.1016/j.ypmed.2003.09.040 · Cited by 63 · cited 2×
“Moreover, smoking was an exceptional habit in the women in this cohort, and typical of the higher social class categories [48].”
BackgroundResultSelf-citationPersistent increase in caffeine concentrations in people who stop smoking.
Benowitz, N. L., Hall, S. M., & Modin, G. (1989) · BMJ · doi:10.1136/bmj.298.6680.1075 · Cited by 56 · cited 1×
“On the other hand, it is also important to note that caffeine half-life is decreased in smokers, contributing to a weaker protective effect under the same dietary exposures [47].”
(2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.089540 · Cited by 47
Caffeinated clues from epidemiology of Parkinson’s disease
Ascherio, A., & Chen, H. (2003) · Neurology · doi:10.1212/01.wnl.0000095213.86899.21 · Cited by 46 · cited 3×
“Separate analyses were conducted for men and women, as previous studies have shown gender-specific effects of caffeine on neurodegenerative diseases [3,12].”
BackgroundResultA systematic review of nutritional risk factors of Parkinson's disease
Ishihara, L., & Brayne, C. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005108 · Cited by 45 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
BackgroundCoffee consumption and risk of ischaemic heart disease — a settled issue?
GYNTELBERG, F., HEIN, H. O., SUADICANI, P., & SØRENSEN, H. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01140.x · Cited by 43 · cited 1×
“We selected factors whose association with neurodegenerative disorders is established or under discussion, namely age [17], education [29, 30], smoking [31,32], alcohol intake [33,34], hypertension [35], diabetes [36], obesity [36,37], and likely to be related to caffeine consumption (especially through coffee intake)…”
BackgroundSurvival-related biases survive well
Saracci, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl263 · Cited by 32 · cited 1×
“In fact, exposure to caffeine in this cohort did not just begin at the time that follow up was initiated, and its influence on the outcomes may have been exerted before the study period, leading to survival bias [45,46].”
BackgroundTakashima, Y., Iwase, Y., Yoshida, M., Kokaze, A., Takagi, Y., Tsubono, Y., Tsugane, S., Takahashi, T., IITOI, Y., Akabane, M., et al. (1998) · Journal of Epidemiology · doi:10.2188/jea.8.106 · Cited by 26 · cited 1×
“Even though most epidemiological evidence suggests that regular intake of caffeinated coffee does not increase the risk of hypertension [50], general public awareness makes hypertensive patients less likely to drink coffee [51].”
Lucas, R., Rocha, O., Bastos, J., Costa, L. D. S. M. J., Barros, H., & Lunet, N. (2009) · PubMed · Cited by 8
Self-citation
Cited by
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“[172] 65+/B 2010 Portugal Cohort N = 648 Cognitive decline +(caffeine, women)”
BackgroundResultInterindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
“, 2011) or more pronounced in women than in men (Santos et al., 2010).”
BackgroundDominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
“A study conducted in Portugal reported an association between caffeine intake with slower cognitive decline [172], while another study conducted in France did not report any association [173].”
ResultAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Metadata
- Authors
- Santos, C., Lunet, N., Azevedo, A., de Mendonça, A., Ritchie, K., & Barros, H.
- Affiliations
- Universidade do Porto (PT)
- Department of Neurology and Laboratory of Neurosciences, University of Lisbon, Lisbon, Portugal
- Nervous System Pathologies: Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France
- Corresponding author
- Santos, Catarina
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-04-14
- Volume
- 20
- Issue
- s1
- Pages
- S175-S185
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1626302529
- Cited by
- 100
- References
- 51
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 12 · 2013: 6 · 2012: 7
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- caffeine consumption, cognitive decline
- MeSH terms
- Aged, Central Nervous System Stimulants, Caffeine, Coffee, Cognition Disorders, Female, Humans, Male, Mental Status Schedule, Neuropsychological Tests, Portugal, Surveys and Questionnaires, Regression Analysis, Retrospective Studies, Risk Factors, Cohort Studies, Confidence Intervals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.